Advertisement

Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 650x65px

News > All

Total search results: 9852 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 11 12 13 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec AG. (8/30/18). "Press Release: Evotec and CHDI Foundation Extend Ongoing Collaboration to Fight Huntington’s Disease". Hamburg. 2018-08-30
BRAIN AG. (8/30/18). "Press Release: DOLCE Core Team Announces Membership Changes in Programme for Natural-based Sweeteners". Zwingenberg. 2018-08-30
Probiodrug AG. (8/30/18). "Press Release: Probiodrug Reports Financial Results for H1 2018 and Corporate Update". Halle (Saale). 2018-08-30
Alnylam Pharmaceuticals, Inc.. (8/30/18). "Press Release: Alnylam Receives Approval of Onpattro (patisiran) in Europe". Cambridge, MA. 2018-08-30
EBD Group. (8/30/18). "Press Release: Global Life Sciences to Convene in Copenhagen for Europe's Largest Annual Biopharma Partnering Conference". Carlsbad, CA & Copenhagen. 2018-08-30
Enzymicals AG. (8/30/18). "Press Release: Enzymicals AG Extends Its Capacity in Business Development". 2018-08-30
Bayer AG. (8/30/18). "Press Release: Bayer Receives US Approval for Modern Hemophilia A Treatment Jivi with a Step-wise Prophylaxis Dosing Regimen [Not intended for U.S. and UK Media]". Berlin. 2018-08-30
BMBF. (8/29/18). "Pressemitteilung: Startschuss für Agentur zur Förderung von Sprunginnovationen". 2018-08-29
Nebula Genomics. (8/29/18). "Press Release: Nebula Genomics Raises $4.3M Seed Financing from Leading Tech and Biotech VCs". San Francisco, CA & Boston, MA. 2018-08-29
Marinomed Biotech AG. (8/29/18). "Press Release: Vienna-based Biotech Company Marinomed on a Growth Path". 2018-08-29
Novartis AG. (8/29/18). "Press Release: Alcon Announces Voluntary Global Market Withdrawal of CyPass Micro-Stent for Surgical Glaucoma". Basel. 2018-08-29
Novartis AG. (8/29/18). "Press Release: European Commission Approves Novartis Combination Therapy Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600 Mutation-positive Melanoma". Basel. 2018-08-29
PhagoMed Biopharma GmbH. (8/28/18). "Press Release: Viruses against Bacteria. Development of Novel Therapeutics Boosted with Millions of Euros". Vienna. 2018-08-28
Roche. (8/28/18). "Press Release: Changes to the Roche Corporate Executive Committee". Basel. 2018-08-28
Apeiron Biologics AG. (8/28/18). "Press Release: Apeiron Expands Executive Board and Appoints Dr. Anderson Gaweco as Chief Medical and Scientific Officer (CMSO)". Vienna. 2018-08-28
Roivant Sciences GmbH. (8/28/18). "Press Release: Urovant Sciences Licenses Novel Gene Therapy for Overactive Bladder". Basel & Irvine, CA. 2018-08-28
Thermo Fisher Scientific Inc.. (8/27/18). "Press Release: Differential Ion Mobility Interface Boosts Proteomics Workflow Performance". Florence. 2018-08-27
Affimed N.V.. (8/27/18). "Press Release: Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets". Heidelberg. 2018-08-27
Novartis AG. (8/27/18). "Press Release: Novartis Receives European Commission Approval of Its CAR-T Cell Therapy, Kymriah (tisagenlecleucel)". Basel. 2018-08-27
Evotec AG. (8/27/18). "Press Release: Evotec and Centogene Sign Global Strategic Partnership on Drug Discovery Projects in Rare Genetic Diseases". Hamburg & Rostock. 2018-08-27
British Heart Foundation. (8/25/18). "Press Release: £30m Global Challenge Launched to Tackle Heart and Circulatory Diseases". 2018-08-25
Bayer AG. (8/24/18). "Press Release: Bayer Secures Approval in the EU for Xarelto (rivaroxaban) for Patients with Coronary or Peripheral Artery Disease [Not intended for U.S. and UK Media]". Berlin. 2018-08-24
Bruker Corporation. (8/24/18). "Press Release: Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH". Billerica, MA. 2018-08-24
Eppendorf AG. (8/24/18). "Press Release: Control and Monitor up to 50 Cyclers from a Central Software Application". Hamburg. 2018-08-24
CMS. (8/24/18). "Pressemitteilung: Bruker Corporation erwirbt mit CMS Mehrheitsbeteiligung an Diagnostikunternehmen Hain Lifescience". Frankfurt a. M.. 2018-08-24
Nanion Technologies GmbH. (8/24/18). "Press Release: Nanion Technologies Opens New Office in Silicon Valley". Newark, CA. 2018-08-24
c-LEcta GmbH. (8/23/18). "Press Release: c-LEcta Lays Foundation for Further Growth and Closes Financing Round". Leipzig. 2018-08-23
Novaremed AG. (8/23/18). "Press Release: Novaremed Announces It Has Raised CHF 6 Million to Prepare for a Phase 2b Study in Diabetic Neuropathic Pain". Basel. 2018-08-23
Evotec AG. (8/22/18). "Press Release: Evotec and Novo Nordisk Form Strategic Research Alliance in Diabetes and Obesity". Hamburg. 2018-08-22
GlucoMe Ltd.. (8/22/18). "Press Release: GlucoMe and Merck KGaA, Darmstadt, Germany to Collaborate on Digital Diabetes Management Project in Vietnam". Yarkona. 2018-08-22
Berlin Cures Holding AG. (8/22/18). "Press Release: Berlin Cures Announces Successful Completion of Phase 1 Study of BC 007 for the Treatment of Cardiomyopathy". Zug. 2018-08-22
BRAIN AG. (8/22/18). "Press Release: BRAIN AG Announces the Creation of SolasCure Ltd. to Continue Development of Aurase". Zwingenberg. 2018-08-22
Knauer Wissenschaftliche Geräte GmbH. (8/22/18). "Press Release: Easy to Use Mass Directed Purification with Single Quadrupole Mass Spectrometer". 2018-08-22
Navamedic ASA. (8/21/18). "Press Release: Renews Multiple Key Distribution Agreements". Oslo. 2018-08-21
Medigene AG. (8/21/18). "Press Release: Medigene and Structured Immunity Announce Collaboration Aimed at Improving T Cell Receptor Development". Planegg. 2018-08-21
Roche. (8/20/18). "Press Release: China National Drug Administration Grants Rapid Approval of Roche’s Alecensa (alectinib) as a Treatment for ALK-positive Lung Cancer". Basel. 2018-08-20
Genedata AG. (8/20/18). "Press Release: Aptevo Therapeutics Deploys Genedata Biologics to Streamline Cancer Immunotherapy R&D". San Francisco, CA. 2018-08-20
Tecan Group Ltd.. (8/16/18). "Press Release: Tecan Accelerates Broad Genomics Strategy with the Acquisition of NuGen Technologies". Männedorf. 2018-08-16
Tecan Group Ltd.. (8/16/18). "Press Release: H1 2018 – Tecan Posts Strong Increase in Sales, Driven by Growth in the Partnering Business". Männedorf. 2018-08-16
Mologen AG. (8/16/18). "Press Release: Mologen and Oncologie. Global Assignment and Co-development Agreement Relating to Mologen’s Lead Compound Lefitolimod". Berlin. 2018-08-16
BioNTech AG. (8/16/18). "Press Release: BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". Mainz & New York, NY. 2018-08-16
Stratec Biomedical AG. (8/15/18). "Press Release: Stratec Reports H1 2018 Figures and Adjusts Financial Guidance". Birkenfeld. 2018-08-15
Merck KGaA. (8/15/18). "Press Release: Merck Awarded Australian CRISPR Nickase Patent for Foundational Genome-Editing Technology". Darmstadt. 2018-08-15
Haplogen GmbH. (8/14/18). "Press Release: Haplogen Enters into a Collaboration with Bayer". Vienna. 2018-08-14
Evotec AG. (8/14/18). "Press Release: Evotec Partner Haplogen Enters into Collaboration with Bayer". Hamburg. 2018-08-14
Artios Pharma Ltd.. (8/10/18). "Press Release: Artios Pharma Announces $84 million (£65 million) Series B Financing. Financing Round Led by New Investors Andera Partners and LSP". 2018-08-10
Merck KGaA. (8/9/18). "Press Release: Merck Reports Solid Organic Performance in Q2 2018". Darmstadt. 2018-08-09
Pieris Pharmaceuticals, Inc.. (8/9/18). "Press Release: Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update". Boston, MA. 2018-08-09
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
Mologen AG. (8/9/18). "Press Release: Mologen AG with Positive Developments in the First Half of 2018. Successful Financing Measures and Continuation of Clinical Studies". 2018-08-09
Evotec AG. (8/9/18). "Press Release: Evotec AG Reports First Half-year 2018 Results and Corporate Updates". Hamburg. 2018-08-09
Nabriva Therapeutics plc. (8/9/18). "Press Release: Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights". Dublin. 2018-08-09
MorphoSys AG. (8/8/18). "Press Release: MorphoSys and I-Mab Biopharma Announce China IND Submission of TJ202/MOR202". 2018-08-08
Epigenomics AG. (8/8/18). "Press Release: Epigenomics AG Announces 2018 Second Quarter and Six Month Financial Results". Berlin & San Diego, CA. 2018-08-08
Consilium Strategic Communications Ltd.. (8/8/18). "Press Release: Consilium – H1 2018 Update". Munich. 2018-08-08
CRISPR Therapeutics AG. (8/7/18). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2018 Financial Results". Zug & Cambridge, MA. 2018-08-07
Akouos. (8/7/18). "Press Release: Akouos Raises $50 Million Series A Financing and Expands Team to Advance Precision Genetic Therapies That Restore and Preserve Hearing". Boston, MA. 2018-08-07
BRAIN AG. (8/7/18). "Press Release: Frank Goebel, CFO of BRAIN AG, Has Asked the Supervisory Board for Early Termination of his Management Board Contract for Personal Reasons". Zwingenberg. 2018-08-07
Boehringer Ingelheim. (8/6/18). "Press Release: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis". Ingelhei 2018-08-06
Eppendorf AG. (8/3/18). "Press Release: First Half Year 2018 – Eppendorf with Broadbased Growth above Market Average". Hamburg. 2018-08-03
Roche. (8/3/18). "Press Release: PRIME Designation Granted by European Medicines Agency for RG6042 for Treatment of Huntington’s Disease". Basel. 2018-08-03
Bruker Corporation. (8/2/18). "Press Release: Bruker Reports Second Quarter 2018 Financial Results". Billerica, MA. 2018-08-02
Boehringer Ingelheim. (8/2/18). "Press Release: Boehringer Ingelheim Launches the Initiative In Reach Africa to Address Key Healthcare Infrastructure and Access Priorities across Africa". Ingelheim. 2018-08-02
Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. 2018-08-01
Qiagen N.V.. (8/1/18). "Press Release: Qiagen Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Faunch of Companion Diagnostics". Hilden & Tokyo. 2018-08-01
MorphoSys AG. (8/1/18). "Press Release: MorphoSys AG Reports Second Quarter 2018 Financial Results". Planegg. 2018-08-01
Boehringer Ingelheim. (8/1/18). "Press Release: Boehringer Ingelheim Achieves Modest Growth in the First Half of 2018". Ingelheim. 2018-08-01
SiO2 Medical Products, Inc.. (8/1/18). "Press Release: BioNTech and SMP to Evaluate SMP’s Next Generation Technology for BioNTech Products". Auburn, AL. 2018-08-01
Evotec AG. (7/31/18). "Press Release: Evotec Repays 50% of EUR 140 M Acquisition Loan". Hamburg. 2018-07-31
Roche. (7/31/18). "Press Release: Roche Purchases Shares in Tender Offer for FMI". Basel. 2018-07-31
Marinomed Biotech AG. (7/31/18). "Press Release: Pascal Schmidt Appointed CFO as Vienna Based Biotech Firm Marinomed Strengthens Its Management Team – Company Reports Strong Growth". Vienna. 2018-07-31
Novartis AG. (7/30/18). "Press Release: Novartis Marks a New Era for Migraine Patients with the EU Approval of Aimovig, a First-of-its-Kind Treatment Specifically Designed for Migraine Prevention". Basel. 2018-07-30
Qiagen N.V.. (7/30/18). "Press Release: Qiagen and Hamilton Launch New Collaboration to Improve Pre-analytical Sample Processing for QuantiFERON-TB Gold Plus". Germantown, MD & Hilden & Reno, NV. 2018-07-30
Metrohm. (7/27/18). "Press Release: Metrohm Acquires B&W Tek". 2018-07-27
Grifols S.A.. (7/27/18). "Press Release: First Half 2018 Results. Grifols Increases Net Profits by 15% to EUR 319 Million, with Sustained Operational Revenue Growth of 7%". Barcelona. 2018-07-27
Novartis AG. (7/27/18). "Press Release: Sandoz Receives European Commission Approval for Biosimilar Hyrimoz (adalimumab)". Holzkirchen. 2018-07-27
Eppendorf AG. (7/27/18). "Press Release: Eppendorf eLABInventory and eLABJournal Software Solutions Now Available". Hamburg. 2018-07-27
Nabriva Therapeutics plc. (7/26/18). "Press Release: Nabriva Therapeutics Announces Pricing of Public Offering of Ordinary Shares of Approximately $50 Million". Dublin & King of Prussia, PA. 2018-07-26
Roche. (7/26/18). "Press Release: Roche Reports Very Strong Performance in the First Half of 2018". Basel. 2018-07-26
Sanofi S.A.. (7/26/18). "Press Release: Sanofi Head of Human Resources Roberto Pucci to Retire, Company Names Caroline Luscombe to Take over October 1st". Paris. 2018-07-26
Definiens AG. (7/26/18). "Press Release: Definiens Strengthens Digital Data and Science Strategy by Appointing Mr. Markus Schunk as Chief Operating Officer". Munich. 2018-07-26
Nabriva Therapeutics plc. (7/25/18). "Press Release: Nabriva Therapeutics Announces Proposed Public Offering of Ordinary Shares". Dublin & King of Prussia, PA. 2018-07-25
Shimadzu Corporation. (7/25/18). "Presentation: Outline & Strategy of Mass Spectrometry Business – Mass Spectrometer Business Presentation Materials (Hiroto Itoi) [Date on Presentation Slide July 3, 2018]". 2018-07-25
Biocrates Life Sciences AG. (7/25/18). "Press Release: AAIC Researchers Report New Data on How Gut Bacteria and Lipid Metabolism May Influence Alzheimer’s and Other Brain Diseases". Innsbruck. 2018-07-25
MorphoSys AG. (7/24/18). "Press Release: MorphoSys Announces Appointment of Jennifer Herron as President of MorphoSys US Inc. and Executive Vice President, Global Commercial". Planegg. 2018-07-24
Nabriva Therapeutics plc. (7/24/18). "Press Release: Nabriva Therapeutics Strengthens Antibiotics Leadership Position with Acquisition of Zavante Therapeutics". Dublin & King of Prussia, PA. 2018-07-24
Agena Bioscience, Inc.. (7/24/18). "Press Release: Agena Announces MassARRAY Technology Selected for Participation in CANCER-ID Consortium". San Diego, CA. 2018-07-24
Azafaros B.V.. (7/23/18). "Press Release: Azafaros B.V. Secures Seed Funding to Develop New Treatments in Rare Metabolic Disorders". Leiden. 2018-07-23
Roche. (7/23/18). "Press Release: Roche Receives CE Mark for Its Accu-Chek Solo Micropump System". Basel. 2018-07-23
SHS Gesellschaft für Beteiligungsmanagement mbH. (7/20/18). "Press Release: First Closing at SHS. Medical Technology Investor Raises over €90 Million for Its Fifth Fund". Tübingen. 2018-07-20
MorphoSys AG. (7/19/18). "Press Release: MorphoSys and Galapagos Sign Global License Agreement for MOR106 with Pharma Partner". Planegg & Mechelen. 2018-07-19
Evotec AG. (7/19/18). "Press Release: Evotec Receives Milestone Payment for Start of Phase II Trial in Its Multi-target Alliance with Bayer". Hamburg. 2018-07-19
Agilent Technologies Inc.. (7/18/18). "Press Release: Agilent and Grabner Instruments Provide Innovative Mobile Testing Solution for the Petroleum Industry". Santa Clara, CA. 2018-07-18
Innovative Medicines Initiative (IMI). (7/18/18). "Press Release: New Antimicrobial Resistance Accelerator Programme Part of Latest IMI Calls for Proposals". Brussels. 2018-07-18
Adocia S.A.. (7/18/18). "Press Release: Adocia Presents First Half 2018 Financial Results. Strategic Alliance Signed with Tonghua Dongbao, the Chinese Insulin Leader". Lyon. 2018-07-18
Glycotope GmbH. (7/18/18). "Press Release: DCPrime and Glycotope Announce Licensing Agreement and Collaboration". Leiden & Berlin. 2018-07-18
S-Biomedic N.V.. (7/18/18). "Press Release: Microbiome Pioneer S-Biomedic Secures Investment and Collaboration with Global Skin Care Company Beiersdorf". Beerse. 2018-07-18
Beiersdorf AG. (7/18/18). "Press Release: Beiersdorf Takes an Equity Investment into S-Biomedic and Collaborates on the Skin Microbiome". Hamburg. 2018-07-18
Roche. (7/18/18). "Press Release: FDA Grants Breakthrough Therapy Designation for Roche’s Tecentriq in Combination with Avastin as First-line Treatment for Advanced or Metastatic Hepatocellular Carcinoma (HCC)". Basel. 2018-07-18
Polares Medical S.A.. (7/17/18). "Press Release: Polares Medical Closes a $25m Financing to Enter Clinical Validation". Lausanne & Palo Alto, CA. 2018-07-17
next pagenext page 1 2 3 ... 11 12 13 ... 97 98 99  next pagenext page



Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 650x65px

» top